---

Cancer Types

Types of Cancer > Lung Cancers > Non-Small Cell Lung Cancer > Conferences

Conferences

OncoLink at PTCOG 2009

Clinical outcomes of proton beam therapy for early stage non-small cell lung cancer. A retrospective analysis of Shizuoka experiences

OncoLink at ASCO 2009

A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer: Initial analysis of Radiation Therapy Oncology Group 0214

OncoLink at ASTRO 2008

Brachial Plexopathy (BP) from Stereotactic Body Radiotherapy (SBRT) in Early-Stage NSCLC

OncoLink at PTCOG 2008

Does Proton Beam Radiotherapy (PBT) Reduce Treatment Related Pneumonitis (TRP) Compared to Intensity Modulated Radiation Therapy (IMRT) in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Concurrent Chemotherapy?

OncoLink at PTCOG 2007

Acute Esophageal Reactions from Proton Beam Therapy and Concurrent Chemotherapy for Non-Small Cell Lung Cancer: Reduction in Incidence and Severity Despite Higher Doses

OncoLink at ASCO 2008

Epidemiology study of never-smokers with non-small cell lung cancer (NSCLC): High percentages of Asian and Hispanic female never-smokers and the significance of Asian ethnicity

OncoLink at ASTRO 2007

Outcome After Stereotactic Radiotherapy in 'High-Risk' Patients With Stage I Non-small Cell Lung Cancer (NSCLC)

OncoLink at ASCO 2007

Motexafin gadolinium (MGd) combined with whole brain radiation therapy prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Pooled analysis of two randomized phase III trials

OncoLink at ASTRO 2006

Analysis of V20 and Radiation Pneumonitis on SWOG 0023: A Phase III Trial of Concurrent Chemoradiation and Docetaxel Consolidation in Stage III Non-small Cell Lung Cancer

OncoLink at ASCO 2006

Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633.

OncoLink at ASTRO 2005

Clinical Application of Positron Emission Tomography (PET) in Designing Radiation Fields in Non-Small Cell Lung Cancer (NSCLC) Patients

OncoLink at WCLC 2005

ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I-III) non small cell lung cancer (NSCLC) patients (pts)

OncoLink at ASCO 2005

Paclitaxel and gemcitabine vs. carboplatin and gemcitabine.  A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)

OncoLink at ASTRO 2004

Neoadjuvant Chemotherapy Followed by Preoperative Radiochemotherapy (hfRTCT) Plus Surgery or Surgery Plus Postoperative Radiotherapy in Stage III Non-Small Cell Lung Cancer: Results of a Randomized Phase III Trial of the German Lung Cancer Cooperative Group

OncoLink at ASCO 2004

A multicenter, phase III randomized trial for stage IIIb/IV NSCLC of weekly paclitaxel and carboplatin vs. standard paclitaxel and carboplatin given every three weeks, followed by weekly paclitaxel

OncoLink at the Chemotherapy Foundation Symposium 2003

CT-2103 (Xyotax): Phase II Trial of a Polyglutamated Paclitaxel Conjugate in Advanced NSCLC

OncoLink at ASTRO 2003

Amifostine As Mucosal Protectant in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Intensive Chemotherapy and Thoracic Radiotherapy (RT): Results of the Radiation Therapy Oncology Group (RTOG) 98-01 Study

OncoLink at ASCO 2003

Age-Specific Sub-Analysis of ECOG 1594: Fit Elderly Patients (70-80 yrs) with Non-Small Cell Lung Cancer Do As Well As Younger Patients (<70 yrs)

OncoLink at ASTRO 2002

Concurrent Chemo-Radiation Results in Equivalent Local and Overall Outcome as Induction Chemotherapy Followed by Surgery for Clinical Stage IIIA Non-Small Cell Lung Cancer

OncoLink at ASCO 2002

Gemcitabine (G) compared with gemcitabine plus carboplatin (GC) in advanced non-small cell lung cancer (NSCLC): a phase III study by the Swedish Lung Cancer Study Group (SLUSG)

OncoLink at ASTRO 2001

Concurrent Chemoradiation for Locally Advanced NSCLC in the RTOG Experience: Effect of Overall Treatment Time

OncoLink at ASCO 2001

Cisplatin/Gemcytobine (CG) vs Cisplatin/Gemcytobine/Vinorelbine (CGV) vs Sequential Doublets of Gemcytobine/Vinorelbine Followed by Ifosfamide/Vinorelbine (GV/IV) in Advanced Non-Small Cell Lung Cancer (NSCLC): Results of a Spanish Lung Cancer Group Phase III Trial

OncoLink at ASCO 2000

Impact of Tumor Control on Survival in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Treated with Concurrent Thoracic Radiotherapy (TRT) and Chemotherapy (CT).

OncoLink at ASTRO 2000

Sequential Vs. Concurrent Chemotherapy and Radiation Therapy for Inoperable Non-Small Cell Lung Cancer (NSCLC) Analysis of Failures in a Phase III Study (RTOG 9410)

OncoLink at ASTRO 1999

Chemoradiation With or Without Surgery for Stage IIIA Non-Small Cell Lung Cancer (NSCLC): A Comparison of Survival and Patterns of Failure